Skip to main content
. Author manuscript; available in PMC: 2024 Jan 3.
Published in final edited form as: J Pediatr. 2020 Jun 28;226:71–79.e5. doi: 10.1016/j.jpeds.2020.06.078

Table I:

Demographic data of healthy term neonates and neonates with neonatal encephalopathy (NE)

Control Cohort (n=30) Total NE Cohort (n=155) Trinity College Cohort (n=57) Children’s National Cohort (n=98) p-value
Median (IQR)
Gestational age (weeks) 39.1 (37.9, 40.0) 39.6 (38, 40.7) 40.7 (40.0, 41.6) 39.0 (38.0, 40.0) 0.22a
Birthweight (kg) 3.3 (3.1, 3.6) 3.3 (2.9, 3.8) 3.6 (3.2, 4.0) 3.1 (2.8, 3.6) 0.73a
First blood gas pH 7.3 (7.2, 7.4) 7.0 (6.9, 7.1) 7.0 (6.9, 7.2) 7.0 (6.8, 7.1) <0.001a
5-minute Apgar score 10 (10, 10) 4 (2, 6) 5 (3, 7) 3.5 (2, 5) <0.001a
Sex, n (%)
Male 12 (40) 88 (57) 38 (68) 50 (51) 0.11b
Female 18 (60) 66 (43) 18 (32) 48 (49)
Mode of Delivery, n (%)
Cesarean 9 (30) 66 (52) 20 (36) 46 (64) 0.04b
Vaginal 21 (70) 61 (48) 35 (64) 26 (36)
Therapeutic Hypothermia, n (%)
Yes 0 (0) 135 (88) 37 (66) 98 (100) <0.001b
No  30 (100)  19 (12)  19 (34)  0 (0)

NE = neonatal encephalopathy.

a

Mann Whitney U test was used for comparison of the control cohort and the Total NE cohort.

b

Fisher’s exact test was used for comparison of control cohort and the Total NE cohort.